Has anyone dealt with tirzepatide and fatty liver?

Clinical perspective, offered as context rather than as advice. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

TrialNerd_Beth said:

It helps to ask what evidence would change your mind before you look at any.

Adding a me-too, because a thread of one person's experience is not much use. The detail I would add is minor and it is already implied above.

TrialNerd_Beth said:

It helps to ask what evidence would change your mind before you look at any.

Coming at TrialNerd_Beth’s question from a different direction. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

Adding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

A narrower follow-up, since the general answer is now clear:

How long did you give it before you decided it was working?